Pharmaceuticals

Hypertension Surge Fuels Bisoprolol Market Growth As Deaths From Hypertensive Diseases Rise Is Supporting Development Across The Bisoprolol Market

May 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Bisoprolol Market Progress Through 2030?

The bisoprolol market has experienced robust expansion in recent years. It is projected to increase from $2.17 billion in 2025 to $2.35 billion in 2026, at a compound annual growth rate (CAGR) of 8.5%. The historical growth in this market can be attributed to the high incidence of hypertension, the established clinical efficacy of beta-blockers, an aging population, the expansion of hospital-based cardiac care, and widespread physician prescribing.

The bisoprolol market size is projected to experience substantial growth in the upcoming years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The expansion during the forecast period is attributable to an increasing burden of cardiovascular disease, improved access to generic medicines, the growth in outpatient cardiac management, the expansion of pharmacy networks, and better treatment adherence programs. Significant trends expected during the forecast period include the rising prevalence of cardiovascular disorders, the growing use of beta-blockers in chronic care, increased adoption of generic cardiovascular drugs, the expansion of retail and hospital pharmacies, and a higher focus on long-term blood pressure management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18977&type=smp

Which Drivers Are Advancing The Bisoprolol Market Growth?

The growing incidence of hypertension is projected to stimulate the expansion of the bisoprolol market. Hypertension is defined as a medical state where blood pressure levels remain persistently elevated beyond the normal physiological range. This condition’s prevalence is on the rise, attributed to increasingly sedentary lifestyles and climbing obesity rates. The bisoprolol market plays a crucial role in hypertension management through its actions of lowering blood pressure, reducing the heart’s workload, and enhancing blood flow. For example, in February 2024, the Singapore Ministry of Health, a Singapore-based government health authority, stated that the prevalence of hypertension among adults reached 36.1% in 2023, an increase from 33.0% in 2022, demonstrating a considerable year-on-year rise. Thus, the increasing occurrence of hypertension is a key factor driving the growth of the bisoprolol market.

Which Segment Divisions Form The Structure Of The Bisoprolol Market?

The bisoprolol market covered in this report is segmented –

1) By Type: Tablet, Capsule

2) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

3) By Application: High Blood Pressure, Coronary Heart Disease, Angina Pectoris, Other Applications

Subsegments:

1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets

2) By Capsule: Immediate-Release Capsules, Extended-Release Capsules, Hard Gelatin Capsules

What Trends Are Affecting The Bisoprolol Market Dynamics?

Leading companies within the bisoprolol market are dedicated to developing innovative therapeutic approaches, including fixed-dose combinations and extended-release formulations, to enhance patient compliance, optimize cardiovascular outcomes, and overcome the limitations associated with traditional therapies. Fixed-dose combinations are medications that integrate two or more active pharmaceutical ingredients into a single tablet, thereby simplifying treatment regimens, while extended-release formulations are engineered to gradually release the drug over an extended period, leading to sustained effects and reduced dosing frequency. As an example, in June 2025, Cadila Pharmaceuticals Limited, an India-based pharmaceutical company, launched Biscado (Bisoprolol) in India, marking its entry into the beta-blocker therapy segment for the management of cardiovascular diseases. This product functions as a highly cardioselective beta-1 adrenergic blocker, prescribed for treating high blood pressure, angina, and chronic heart failure by effectively lowering heart rate and blood pressure to alleviate strain on the heart. Its clinical effectiveness is supported by studies demonstrating significant reductions in mortality, sudden cardiac death, and hospital admissions for heart failure. Biscado is available for once-daily administration and in fixed-dose combinations with other antihypertensive agents, consistent with global cardiovascular treatment guidelines and aimed at improving patient adherence within India.

Which Key Players Are Active In The Bisoprolol Market?

Major companies operating in the bisoprolol market are Merck & Co. Inc., Abbott Healthcare Pvt Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Dr. Reddy’s Laboratories Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Ipca Laboratories Limited, Medreich Limited, Alembic Pharmaceuticals Limited, Accord Healthcare Limited, Zydus Lifesciences Limited, Zentiva Group, Taj Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Suanfarma, Rusan Healthcare Limited, VHB Lifesciences Limited, Synnat Pharmaceuticals, Vidakem Lifesciences Pvt Ltd, Pluviaendo Pharmaceuticals

Access The Complete Bisoprolol Market Report:

https://www.thebusinessresearchcompany.com/report/bisoprolol-global-market-report

Which Region Has The Strongest Presence In The Bisoprolol Market?

North America was the largest region in the bisoprolol market in 2025. The regions covered in the bisoprolol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Bisoprolol Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=18977&type=smp

Browse Through More Reports Similar to the Global Bisoprolol Market 2026, By The Business Research Company

Metoprolol Tartrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/metoprolol-tartrate-global-market-report

Bi Specific Mab Market Report 2026

https://www.thebusinessresearchcompany.com/report/bi-specific-mab-global-market-report

Clopidogrel Market Report 2026

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795